Appointment booking for Dr. Sandra Maldonado-rivera, MD is currently not available.Dr. Sandra Maldonado-rivera, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Sandra Maldonado-rivera, MD (she/her) is a Infectious Disease Doctor in Dorado, PR with over 17 years of experience. What is your opinion of Dr. Sandra Maldonado-rivera, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Sandra Maldonado-rivera, MD has received over $10,849 which includes payments from the following companies:
$5,490.89 from Merck Sharp & Dohme Corporation
$3,370.28 from Gilead Sciences Inc
$901.02 from Allergan Inc.
$460.70 from Janssen Pharmaceuticals, Inc
$179.90 from Janssen Products, LP
$153.76 from ViiV Healthcare Company
$96.67 from AstraZeneca Pharmaceuticals LP
$79.94 from Theratechnologies Inc.
$53.02 from AbbVie, Inc.
$44.30 from Pfizer Pharmaceuticals LLC
$18.75 from E.R. Squibb & Sons, L.L.C.
Payments received by Dr. Sandra Maldonado-rivera, MD were from the following categories:
$3,506.04 Travel and Lodging
$3,500.00 Consulting Fee
$2,127.36 Food and Beverage
$1,500.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!